Submit Share Grow. Free press release distribution for small business
RSS RSS facebook Twitter Contact Us

Exclusive and one of the best business news portals for small and medium enterprises in India

Breaking News
Press Release 
Global anti aging trials direct to the public launched by UK company based on cutting edge science
Posted for Mackenzie Protocol Plc by 1888pressrelease on February 24th 2011 and filled under Technology
 
Nobel prize based research into telomeres and the enzyme telomerase coupled with research into telomerase activation and a rare molecule in a natural supplement extracted from the root of an Asian plant.
 

We are pleased to announce the first Internet worldwide UK based longevity trial, to be of interest to the 50 plus age group, at an affordable price. The Mackenzie Protocol is an anti aging trial offered directly to the public based on the discovery of telomeres and telomerase.

Telomeres are caps at the end of the DNA proven to be an aging factor and the subject of the 2009 "Nobel prize in physiology or medicine."

Telomerase is an enzyme that affects the length of the telomeres and the life of cellular reproduction and longevity.

The Protocol is based on a molecule in a natural nutritional supplement extracted in minuscule quantities from the root of a rare Asian plant. Additionally, the protocol includes a new cutting edge laboratory method for testing for critically short telomere lengths from blood samples. By law, no medical claims can be made by the Mackenzie Protocol PLC who insist that clients must refer to a qualified medical practitioner first.

The research into the main supplement shows properties for slowing down aging and degeneration at a cellular level. At the high level of purification offered it costs many times more than the same cost of it's weight in gold,

Previous and ongoing pioneering anti aging trials based on sound scientific principles and cutting edge science. using this nutritional supplement as a base have already taken place over a number of years in the USA.

The previous USA trials were funded by the participants themselves paying fees of tens of thousands of dollars each. Now this similar protocol is available in the UK at a mere fraction of the original USA cost.

New scientific papers on this subject are being published on almost a weekly basis, You wont find many doctors knowing much about this cutting edge science yet as drug companies are not interested in promoting natural substances. They can't patent them and and get no exclusive profit potential for them even though many similar products offer enormous potential benefits to the public and massive potential savings for the national health service.

Internet growth has made much good information available to intelligent people who are now able to make informed choices.

Many progressive medical practitioners worldwide are changing their attitude and becoming involved in a movement towards what is known as Integrative Medicine.

Integrative Medicine principles dictate that natural remedies should be tried first before moving on to drugs with unwanted side effects. If this movement held more sway in the UK it could save the national health service millions, possibly billions, of pounds.

http://www.mackenzieprotocol.com

 
Received 1 comment Show Showing 1 of 1 comment
Browse more on: Technology More News
Tags (click for more Related Topics): Technology, research, Medical, Company, Public, Science
   
 
Leave a comment Login/Register Now
(Your message will be posted as 'Guest' because you're not logged in as a member. )
 
Name (Required)
E-mail (Required)... (will not be published)
Website
Security check
Please type the characters you see in the picture below *
 
Popular Topics
SPONSORED BY
 
 
Opinions, advice, statements, offers, or other information or content made available through IndiaCompanyNews are those of their respective authors. Accuracy and timeliness of all data is not guaranteed. If you have any questions regarding information in Company News/Press Releases please contact the organization listed in the press release, Issuers and not IndiaCompanyNews are solely responsible for the accuracy of the content. Web site logos and headlines are the property of their respected companies. Use of this site constitutes acceptance of our terms of use and privacy policy.